EUVIMEDEUVIMED entdecken
Open Access

Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories

Johannes Oldenburg, Andreas Tiede iD, Jayanthi Alamelu, María Teresa Álvarez Román, Christoph Bidlingmaier, Pål Andre Holme, Flora Peyvandi, Eva Bednar, Eveline Nüesch, Stefan Lethagen iD

TH Open · 29.07.2026 · 10 (CP)

DOI: 10.1055/a-2894-5837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TH Open, erschienen am 29.07.2026. Verfasst von Johannes Oldenburg und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Haematology and Transfusion MedicineUniversity Hospital Bonn, Medical Faculty, University of BonnBonnGermany. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitieren

Abstract (Originalsprache)

Objective

To assess the effectiveness of recombinant factor VIII Fc fusion protein (efmoroctocog alfa; referred to herein as rFVIIIFc) prophylaxis in people with hemophilia A (PwHA) stratified by age, body mass index (BMI), disease severity, and inhibitor history included in the A-SURE (NCT02976753) and PREVENT (NCT03055611) real-world studies.

Methods

PwHA receiving at least one prescription of rFVIIIFc and ≥3 months of follow-up during the prospective periods were included. Post hoc analyses were performed for the overall analysis population and subgroups based on age, BMI, disease severity, and those with and without previous inhibitors. Effectiveness endpoints were annualized bleeding rate (ABR), annualized joint bleeding rate (AjBR), injection frequency, and factor consumption in the prospective period.

Results

Overall, 333 PwHA were analyzed. ABRs and AjBRs, generally, were low across the different subgroups (range of medians, 0.0–0.6 for both ABRs and AjBRs, except for ABRs in PwHA aged ≥65 years). Injection frequencies (n injections/week) were comparable across subgroups (range of medians, 2.0–2.3), and factor consumption was generally similar (range of medians, 68.3–100.0 international units/kg/week), although with slightly higher factor consumption in pediatric PwHA and lower consumption in the overweight or obese BMI groups.

Conclusion

These post hoc analyses support the effectiveness and, therefore, use of rFVIIIFc prophylaxis in PwHA across all ages, BMI categories, severities, and for those with a history of inhibitors.

Schlagwörter

Stichwörter der Autor:innen

factor VIIIhemophilia Aprospective studies

Autor:innen und Institutionen

  • Institute of Experimental Haematology and Transfusion MedicineUniversity Hospital Bonn, Medical Faculty, University of BonnBonnGermany.
  • Department of Hematology, Hemostasis, Oncology and Stem Cell TransplantationHannover Medical SchoolHannoverGermany.
  • Paediatric HaematologyEvelina London Children's Hospital, Guy's and St Thomas' NHS Foundation TrustLondonUnited Kingdom of Great Britain and Northern Ireland.
  • Department of HaematologyLa Paz University Hospital-IdiPazMadridSpain.
  • Department of PediatricsDr. von Hauner Children's Hospital, Pediatric Hemophilia Center, LMU MunichMunichGermany.
  • Department of HaematologyOslo University Hospital, Institute of Clinical Medicine, University of OsloOsloNorway.

ORCID-Profile: Andreas Tiede, Stefan Lethagen

Zitieren

APA

Oldenburg, J., Tiede, A., Alamelu, J., Álvarez Román, M. T., Bidlingmaier, C., Holme, P. A., Peyvandi, F., Bednar, E., Nüesch, E., & Lethagen, S. (2026). Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories. TH Open, 10(CP). https://doi.org/10.1055/a-2894-5837

Vancouver

Oldenburg J, Tiede A, Alamelu J, Álvarez Román MT, Bidlingmaier C, Holme PA, et al. Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories. TH Open. 2026;10(CP). doi:10.1055/a-2894-5837

BibTeX
@article{Oldenburg2026,
  author = {Oldenburg, Johannes and Tiede, Andreas and Alamelu, Jayanthi and Álvarez Román, María Teresa and Bidlingmaier, Christoph and Holme, Pål Andre and Peyvandi, Flora and Bednar, Eva and Nüesch, Eveline and Lethagen, Stefan},
  title = {Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories},
  journal = {TH Open},
  year = {2026},
  volume = {10},
  number = {CP},
  doi = {10.1055/a-2894-5837}
}
Kostenlos starten →